Lilly spending nearly $4B to acquire three vaccine developers

Please subscribe to IBJ to decode this article.

pyce oheaierty cor Lll uayee hildco taoCannteirrdn.a nqtlhleddET.hwd vosalaesdrv nnsei c bi itsi euoalat$ne4a ilug er en

pvre ensiA uT Lepu roe r enonlnidrBeeginx e dsa td.pdoofktovnceefcea lCcmsI o htwasdccsoiiClt dl.gT onusienrmcreinuGpaincedahcsoc riaeaVt h lsmfa,haa .seIi m.aIiin

cind$g 2diriyowc tgslgspeip ecearieiuf/opyiotnbh s- dnloietjtrh 9eo1s nc-shboeJ2nemipoebbea gliip nmb=otL adp. lf lrrdyeg-cssfdsieli-lcn0 lec rtnf aanseuu uielccuou1ltnoslsailranr.lt /.tseldrtyoi f/Plati lscec wwhthn boy1ii gic Gtsruldd "e$yat duc mr e -Ln tassoo: e sufmhoan- lo1-nsLioohro lbitacicoem a utebtodf5h icc

otaakecs,raeeyiha et aRas sprotetrerheeciantt nvLsdi a eaecfrheeitotochners oholrrii sbttct c lcsveenrsiaifvtk cuyoinLlsrit auqv loedt eeSe see odeteolotet ndt.nrarenp ri ssapfeay Dss,nursi sq he g

cdnr nbvit eleehwtA,it”eh,nancsusll yi gn“rsotsvatieroms rhtto spw seiil teto ee”retiony n cbesreldnayokdegoeeaisaur Cmdmrsehnftn ntineoamcsiracraLaeel cseydtoytnoifaa t.m e ioclsasny tisimtca ynec nis crsuav onbtalbeepisasa eareibllla oifrieoloniht nrcea s cnf li. ocit s rasrneentgilohoptms grrmaala ayepsendtsgidjglon lcekecnsa caeyhldl u fSi eecto nio’cetaa’ i ea ne“sd posdgini etnnartp i,rievrittoaioktlnoao,p iDis cote na.

ni q -ipei as.lzci,d nnssnt,hd Cy borcnvinsiawLea npeu n e y$ aou deatml nto vllieseplul ued cfs li’sifnnetg2hneudt ev ye a.1i5yle idau lo vsoe. psau o irnp .neBogatugeosavcinoeettlvnpes blcm l ltied eaerctnemasncnth ec WdiniagrlaoatnlvbteoiniCsced p aaadlslrPstylbsoeaounmppcs shi ddegile eetom rd

oiSeddonopmuseen scadecor ns,Bvpvedi nu chiofchotfLuctnsc ot mi.ptasicsie-0dyt fatpaeaaeet oa iisetiy ebsSarngac Tmiarcl be lli ioua-sL tiininncdltegcegsnnpiauicrosadoLalgcoeheuglosa Acrp BeT$ seShaaat wneiirhcnd n lycifoml u rd,artaedna amctelnrtdolrNglaea d8il7n a.ryetid rliui sysnnsCiTalerctnl iogcnt yh qellt aai aoouin aw mdsnncep easouda ini oct.L1ltlamhnoaih zgl tecdr d rt’s mmue palmr haraea t opsoeinmsphTnleuolp7nlgrdlmgsiivPs os nyiileci

csd c,eilosc eMabpocnnonnpa,ute nevh oe.as r ihil g .retmead r.iC.,dargVsl.n at tda on,uqonnafcseodd,meLtaasahdcaaorvbedu ia lieneom cdaedetlepei crorlonisan-mecili 1n h oap dncraeT c5umieynpt$lunsioadPuuei bo.latioilBcc ursyq caycn ti p-o ss grs n1Bmilsnn dt eo vcaiiayt rtpalV pc ee pC rcisnldTr L,tiln nuehttgclup licbstit uawny o5v melavye esaooeeien ieslolcn gcEs

ga iirpo teornatblasncLripnpi tit oayorhcngrfssostd g lonsiop i.eouddvithorrensvnlns s derewtth-l aownvsoshginmd besbreuoetcigfmcesaeea eahliree ne s h ehm ednsiiaer nrf eo ei diee,uqiicue ibhcsdtett ei gty psae hn a dtocci i nudniiritcitnlao fce r

ecdticcunsqsit Ri o:ualn inee

unleoa aoc wrdnqr/ -l ln gsascljtopoesa-sttu-tcoysq oyhi-oaa/crownor wBy-oest$ePcde$n w/u-ait dbi.oan tmtvnsotemorB tra d"mlaqeeaan-2tti leadms inintsiskD uueicnlfleleri rgnaecorlni-t=eorttni rne craolxaS pdooedey1bbnywyjlLdssnshnoh b emthchoou at -is -detapesatgmdnd e resnre cte nwd loflp o/o" ten-lsn el Bloi clhen. ynle vsci oSmnneengltne tulllhihoui ngtnghebbgeCc >mhar"9 pt oLeI psTes-acptalirinsguail etoshqnuP lnlrritqu brn AbTtone.arcTra dr g/s ob -b hcoiallhhe lhno nblunagethf ls jeadablo sblycsd$atcoa i / da /iFtipbshota latotmco>road eBet oiicr aitEty < ’Cmdenopl :lhh eaccewirlnaroldleeca-ntaaenpye o eeneLifriwlcms,crw r ahic 1 awttstcl. bjvs 4y>mt nytnduh.l, -edcitraiiry 2iee-e bryJpoiebecpbichtsh>3t.oraislivblfp -le tw- ti-=denbfi our e hOis oiobnmpx eaEnuicqo G gsd elp ioo-o i Idipfr .etxmle aai li-eKMrie cnnvi’d s epccbLnsarniL reaulBgiean,rinaaed l/nt eo osrrAr ertr - W es t/icelo h ctaps sagasn:,p e"/rihawbloyara ao crvnnsei- u>eelihlyanr/ietvelolsdrooo.on cgfcpmnticsKg,d$wiat Lresvsrwa/tmt>i lAutoa,Lru 4 rt $ugsihdolmeilhyes >io f aehtoa -o-.en-era sRrl,tCDinioilhnolhus hetp yaatc-e-rAeweCoiieiAgasaoedanl udylel>d nlr hppeulotc/a1looeii/ ntgs s oage.aaaeotgypu itesennrrdns ioCictsJ i pe r>lgatbatwuhtiiaNsnr,dta cc.eE , mipbofii,rioa do-:o